.png "Janet Woodcock"){kind=small}
Robert Califf
Search results
Janet Woodcock (born August 29, 1948) is an American physician serving as Principal Deputy Commissioner of Food and Drugs, having previously served as Acting Commissioner of the U.S. Food and Drug Administration (FDA).
- Roger Miller
- Robert Califf
Feb 17, 2022 · Janet Woodcock is the FDA’s Principal Deputy Commissioner and the former Acting Commissioner of Food and Drugs. She has led the agency’s drug evaluation and approval, biologics research, and COVID-19 response, and received many honors for her public health career.
- Principal Deputy Commissioner
- Office of The Commissioner
This Wednesday will be Dr. Janet Woodcock’s last day at the US Food and Drug Administration (FDA), capping a remarkable 38-year career at the agency. She’s been called one of the most powerful and influential drug regulators worldwide.
Nov 16, 2023 · U.S. Food and Drug Administration (FDA) Principal Deputy Commissioner Dr. Janet Woodcock, who led the regulator during the height of the COVID-19 pandemic as acting chief, plans to retire early...
Nov 16, 2023 · Woodcock, a 37-year veteran of the FDA, was acting commissioner at the beginning of the Biden administration and a key decision-maker on controversial drugs and COVID-19 response. She will leave the agency after facing criticism for approving opioids, Alzheimer’s and muscular dystrophy drugs.
Nov 17, 2023 · The longtime regulator, who led the agency's drug evaluation center and Covid-19 response, plans to leave in early 2024, FDA Commissioner Robert Califf announced. Woodcock is a legend in public health and has made enduring improvements in FDA operations, according to former and current officials.
Nov 16, 2023 · Principal Deputy FDA Commissioner Janet Woodcock, who joined FDA in 1986 and led the drug center, will step down from her role in 2023. She oversaw the approval of biotechnology-based treatments, antibody drugs, generic drugs, and over-the-counter drug reforms.
